Salvianolic Acid B Attenuates Liver Fibrosis via Suppression of Glycolysis-Dependent m1 Macrophage Polarization
Current Issues in Molecular Biology · 29.07.2025 · 47 (8) · 598
DOI: 10.3390/cimb47080598 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 29.07.2025. Verfasst von Hao Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy of College, Hunan University of Chinese Medicine, Changsha 410208, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hunan University of Traditional Chinese Medicine, Hunan University of Chinese Medicine Innovation Foundation for Postgraduate.
Abstract (Originalsprache)
Liver fibrosis, a critical pathological feature of chronic liver injury, is closely associated with macrophage-mediated inflammatory responses and metabolic reprogramming. Blocking the fibrosis process will be beneficial to the treatment and recovery of the disease. Liver macrophages are a remarkably heterogeneous population of immune cells that play multiple functions in homeostasis and are central to liver fibrosis. Glycolysis-mediated macrophage metabolic reprogramming leads to an increase in the proportion of M1 macrophages and the release of pro-inflammatory cytokines. The present study aimed to investigate the therapeutic effect and mechanism of acid B (SAL B) against carbon tetrachloride (CCl4)-induced liver fibrosis. Here, we demonstrate that SAL B reduced the production of inflammatory factors in CCl4-induced liver fibrosis. Mechanistically, SAL B increased the expression of migration inhibitor 1 (MIG1) by inhibiting DNMT1-mediated methylation of the MIG1 promoter. Subsequently, MIG1 reduced the transcription of lactate dehydrogenase A (LDHA) and hexokinase 2 (HK2) which blocked glycolysis-mediated macrophage M1 polarization. In summary, our results suggested that SAL B is a promising intervention for ameliorating liver fibrosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacy of College, Hunan University of Chinese Medicine, Changsha 410208, China.
- Key Laboratory of Modern Research of TCM, Education Department of Hunan Province, Changsha 410208, China.
ORCID-Profile: Yang Tan
Förderung
- National Natural Science Foundation of China
- Hunan University of Traditional Chinese Medicine
- Hunan University of Chinese Medicine Innovation Foundation for Postgraduate
Zitieren
APA
Song, H., Li, Z. W., Xu, W., Tan, Y., Kuang, M., Pei, G., & Wang, Z. Q. (2025). Salvianolic Acid B Attenuates Liver Fibrosis via Suppression of Glycolysis-Dependent m1 Macrophage Polarization. Current Issues in Molecular Biology, 47(8), 598. https://doi.org/10.3390/cimb47080598
Vancouver
Song H, Li ZW, Xu W, Tan Y, Kuang M, Pei G, et al. Salvianolic Acid B Attenuates Liver Fibrosis via Suppression of Glycolysis-Dependent m1 Macrophage Polarization. Current Issues in Molecular Biology. 2025;47(8):598. doi:10.3390/cimb47080598
BibTeX
@article{Song2025,
author = {Song, Hao and Li, Ze-Wei and Xu, Wei and Tan, Yang and Kuang, Ming and Pei, Gang and Wang, Zhi-Qi},
title = {Salvianolic Acid B Attenuates Liver Fibrosis via Suppression of Glycolysis-Dependent m1 Macrophage Polarization},
journal = {Current Issues in Molecular Biology},
year = {2025},
volume = {47},
number = {8},
pages = {598},
doi = {10.3390/cimb47080598}
}
EUVIMED